Pharmacological Treatments for Constipation and Opioid-Induced Constipation

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This article addresses the management of chronic constipation and opioid-induced constipation. Apart from increasing dietary fiber, there are several classes of medications that can be used for treatment of constipation, and these include osmotic and secretory laxatives, agents that impede the re-absorption of endogenous bile acids resulting in stimulation of motor and secretory functions in the colon, and agents that stimulate the motor function of the colon thereby propelling stool towards the rectum. Several drug classes are also available for the treatment of opioid-induced constipation including peripherally active mu-opioid receptor antagonists, and some of the same secretory agents and prokinetics that are used for chronic constipation. For both of these indications, there have recently been studies that compared efficacy and safety of the available drugs through network meta-analyses, which are also summarized in this article.

Original languageEnglish (US)
Title of host publicationComprehensive Pharmacology
PublisherElsevier
Pages76-99
Number of pages24
Volume5
ISBN (Electronic)9780128204726
DOIs
StatePublished - Jan 1 2022

Keywords

  • Bisacodyl
  • Guanylate cyclase
  • Linaclotide
  • Lubiprostone
  • PAMORA
  • Picosulphate
  • Plecanatide
  • Prokinetics
  • Prucalopride
  • Secretagogues
  • Tenapanor

ASJC Scopus subject areas

  • General Pharmacology, Toxicology and Pharmaceutics
  • General Medicine

Fingerprint

Dive into the research topics of 'Pharmacological Treatments for Constipation and Opioid-Induced Constipation'. Together they form a unique fingerprint.

Cite this